Endoscopic Ultrasound Needles Market Trends

Growth Drivers

• Emergence of minimally invasive surgeries (MIS): The shifting preference toward procedures with lesser recovery times, fewer complications, and improved efficiency is a major driver in the market. Testifying to the same, a 2024 study published in an AcademicMed article unveiled that patients in the MIS group had notably better overall satisfaction ratings in comparison to those in the open surgery (OS) group (9.13 vs 7.45). Additionally, the willingness to recommend MIS treatment was 17% higher than the OS. Such clinical evidence directly supports the increased adoption of EUS-guided needle procedures in modern healthcare practice.

• Advancements in product design and efficacy: Continuous discoveries in the market are improving diagnostic accuracy and procedural efficiency, boosting adoption. Advanced products recently launched in this sector now offer greater flexibility and tissue acquisition capabilities, allowing for more reliable diagnoses of gastrointestinal and pancreatic conditions. Enhanced imaging systems, such as high-resolution ultrasound and elastography, also support better visualization of target lesions, increasing diagnostic confidence. Exemplifying the same, in February 2024, a research team in this category at UC Davis Health established the efficacy of a new ultrasound-guided EUS needle, EndoDrill GI, by successfully performing a core biopsy of a pancreatic tumor, outperforming regular needles.

• Growing therapeutic usage of endoscopy: The increasing use of endoscopy in treating certain clinical ailments is also a propeller behind the expansion of the market. Beyond disease detection, EUS is increasingly being utilized for several therapeutic procedures, such as cyst drainage, targeted drug delivery, and tumor ablation, which is amplifying the use of commodities available in this sector. Testifying to such applicability, in March 2023, a comparative analysis between ultrasound-guided needle release plus corticosteroid injection and mini-open surgery for carpal tunnel syndrome was released by Frontiers. It underscored shorter operation time, quicker recovery, smaller wounds, and lower cost of the needle therapy than the conventional open surgery.

Historic Trends in the Patient Pool Growth of the Market

The Rise of Minimally Invasive Surgery: 16 Year Analysis

Source: NLM

Pricing Variability Among Different Product Types in the Market

Comparison of Payers’ Pricing Between 19G and 22G Franseen-tip Needle Biopsy (FNB) for Liver (2024)

Source: NLM

Challenges

• Heightening expenses of manufacturing and compliance: The increasing costs of sourcing required raw materials and producing high-precision tools act as significant cost barriers in the market. Besides, the tightening of medical device manufacturing protocols is also contributing to such inflation, hindering both patient accessibility and company profitability in this sector. However, the utilization of public-private partnerships (PPPs), product innovation, and automated assembly lines is minimizing this disparity and benefiting the merchandise with greater profit margins.

• Competition with reprocessed devices: Despite the growing acceptance, the market still lacks in competency with refurbished equipment use in terms of cost sensitivity among healthcare providers. Evidencing the same, in November 2023, the CDC unveiled that more than 30% of hospitals in the U.S. reuse at least one type of single-use medical device. This not only raises concerns about performance consistency and patient safety, but also limits the sector's exposure to attaining substantial purchase. To bridge this gap, pioneers are cultivating value-based pricing models, such as subscription-based procurement, to counter reprocessed devices with reliable alternatives.